Hospitals Keep Improving Patient Safety in 2025
Patient survival rates in Q2 2025 are nearly 30 percent higher than expected according to a new report by AHA and Vizient
Read More
Dear Mr. Buffett: Healthcare Isn’t Hopeless
Truth is, there are hugely positive tailwinds at our back. But the way we’ve been thinking about the problem is holding us back from solving it. Here’s why. The post Dear Mr. Buffett: Healthcare Isn’t Hopeless appeared first on MedCity News.
Rock Health: Digital Health Funding Drops in 2024, Investors Shift Focus to Early-Stage Startups
There was a slight decrease in 2024 digital health venture funding compared to 2023, according to a new report from Rock Health. This partially due to increasing investor interest in earlier-stage startups. The post Rock Health: Digital Health Funding Drops in 2024, Investors Shift Focus to Early-Stage Startups appeared first on MedCity News.
Inside a Big Q3: Venture Capital for Digital Health Continues to Grow
Digital health funding remains strong so far this year, with $9.9 billion raised through Q3 and megarounds driving record deal sizes. However, the path to scale is becoming less predictable, as startups increasingly rely on unlabeled rounds and face longer timelines to reach Series B. The post Inside a Big Q3: Venture Capital for Digital…
Pulmonary Arterial Hypertension and Cancer: Unveiling Parallels in Epidemiology, Clinical Pathways, and Therapeutic Strategies
That is the title of a paper I published today in Journal of Market Access & Health Policy with co-authors by Karim EI-Kersh, Nadine Zawadzki, Catelyn Coyle, Shurui Zhang, Dhruv Dalal, Anna Watzker, and Dominik Lautsch. The abstract is below: Pulmonary arterial hypertension (PAH) and cancer share high mortality and complex prognoses. Due to PAH’s…
The Healthcare Executives Joining the AI Conversations at INVEST Digital Health
AI in healthcare is the theme of the INVEST Digital Health 2025 conference, scheduled for September 18 in Dallas at Pegasus Park. Register today! The post The Healthcare Executives Joining the AI Conversations at INVEST Digital Health appeared first on MedCity News.
Precision Oncology Startup Kivu Unveils $92M for More Stable & Durable ADC Cancer Drugs
Novo Holdings led the Series A investment in Kivu Biosciences, developer of next-generation antibody drug conjugates for solid tumors. The startup’s ADCs and technology were licensed from Synaffix, a Lonza subsidiary. The post Precision Oncology Startup Kivu Unveils $92M for More Stable & Durable ADC Cancer Drugs appeared first on MedCity News.
How Community-Based Peer Support Enhances Health Outcomes
Webinar addresses innovative approaches to improve member outcomes in underserved communities
PCR Comes to the Home With FDA Authorization of Visby’s OTC Sexual Health Test
The FDA granted marketing authorization to a Visby Medical at-home PCR test for three common sexually transmitted infections. The Visby test yields results in about 30 minutes. The post PCR Comes to the Home With FDA Authorization of Visby’s OTC Sexual Health Test appeared first on MedCity News.
Lōvu Health Rakes In $8M for Maternal Health Platform
Lōvu Health’s Series A round was led by SJF Ventures and included participation from Rogue Women’s Fund, Symphonic Capital, Emmeline Ventures and Majella Ventures. The post Lōvu Health Rakes In $8M for Maternal Health Platform appeared first on MedCity News.